
Bristol-Myers Squibb is entering into an agreement with the California Institute for Biomedical Research to develop new treatments for fibrotic …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

